Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 05, 2026
Why Is Vishay Precision Group (VPG) Stock Down -22.92% Today?

Why Is Vishay Precision Group (VPG) Stock Down -22.92% Today?

Key Takeaways

  • VPG shares tumbled approximately 22.92% on Wednesday following the release of fiscal second-quarter 2026 earnings that fell far short of profit expectations.
  • Adjusted earnings per share came in at just $0.04, missing analyst consensus estimates of $0.11 to $0.19 by a margin of roughly 64% to 79%.
  • Foreign exchange headwinds slashed operating profit by $3.3 million year-over-year, while a temporary ERP system disruption at the KELK business delayed roughly $3 million in steel-related shipments.
  • Revenue rose 11.7% to $83.9 million and bookings reached $95.5 million with a book-to-bill ratio of 1.14, but the strong demand story was completely overshadowed by margin compression.
  • The broader market rallied to fresh records, with the Dow and S&P 500 hitting all-time highs, confirming the selloff was entirely company-specific.
  • Traders are now watching whether management can convert its robust backlog into improved profitability in the second half of fiscal 2026.

Opening Summary

VPG, the stock ticker for Vishay Precision Group, Inc.—a Pennsylvania-based designer and manufacturer of precision sensors, weighing solutions, and measurement systems—plunged approximately 22.92% in Wednesday's trading session. The shares dropped from Tuesday's closing price of $101.00 to an intraday level near $77.85 as of mid-afternoon, erasing billions in market capitalization in a single session. The brutal selloff was triggered by the company's fiscal second-quarter 2026 earnings report, released before the market opened on August 5, which revealed a dramatic earnings miss driven by foreign exchange headwinds, operational disruptions, and margin compression—despite revenue that grew double digits year-over-year and orders that remained robust.

Earnings Miss: A Profitability Shock Despite Revenue Growth

The immediate catalyst behind Wednesday's collapse was unmistakable: VPG reported adjusted earnings per share of $0.04 for its fiscal second quarter ended July 4, 2026. That figure fell dramatically short of the $0.11 to $0.19 range that Wall Street analysts had modeled. On a GAAP basis, the company posted a net loss of $1.7 million, or $0.13 per diluted share—a sharp reversal from net earnings of $0.02 per share in the same quarter a year earlier.

Revenue of $83.9 million did climb 11.7% from the prior-year period and was broadly in line with expectations, but it was not enough to offset the bottom-line disappointment. The company's GAAP operating margin flipped to negative 0.4%, compared with a positive 3.6% a year ago, while adjusted operating margin contracted to a razor-thin 1.7% from 5.4%. Adjusted EBITDA came in at just $5.5 million, translating to a margin of 6.5%.

Management acknowledged during the earnings call that normalized EBITDA would have been closer to $9 million to $10 million after stripping out the impact of currency fluctuations, product mix headwinds, and the KELK shipment delays. But for a stock that had surged approximately 268% over the preceding twelve months and was trading at a price-to-earnings ratio above 226, investors were in no mood to look past the headline miss.

Foreign Exchange and Operational Headwinds

Three distinct factors converged to compress VPG's margins during the quarter. First, unfavorable foreign exchange movements reduced operating profit by $3.3 million versus the prior-year period and by $900,000 sequentially. With significant international operations spanning Europe, Israel, and Asia, the company remains highly sensitive to currency swings.

Second, the rollout of a new enterprise resource planning (ERP) system at the company's KELK steel-related measurement business caused supply chain disruptions that delayed approximately $3 million in shipments. Those orders remain in backlog and are expected to be fulfilled by year-end, but the timing temporarily depressed revenue and profitability in the Measurement Systems segment.

Third, an unfavorable product mix, coupled with higher materials costs and wage increases, further eroded gross margins. The Sensors segment—the company's growth engine—saw its gross margin decline to 31.5% from 34.8% sequentially, while the consolidated gross margin slipped to 38.6% from 40.7% a year earlier.

Strong Orders and AI Exposure: The Bull Case Ignored

Buried beneath the earnings disappointment were several genuinely positive developments that the market chose to disregard. Total bookings reached $95.5 million, producing a book-to-bill ratio of 1.14—the seventh consecutive quarter at or above 1.0. Backlog expanded to $136 million, up $11 million from the first quarter, positioning the company for stronger revenue in the second half of fiscal 2026.

The Sensors segment delivered standout performance, with record quarterly bookings of $48.1 million and a book-to-bill ratio of 1.44—driven by surging demand for precision resistors serving AI-related semiconductor test equipment, data center infrastructure, and aerospace and defense applications. The company also disclosed that it had received a vendor nomination letter from its first humanoid robotics customer and booked approximately $500,000 in related orders during the quarter, with a production ramp expected in the second half of 2026. These AI-adjacent growth vectors had been a key part of the stock's dramatic rally over the past year.

Market Context and Trading Activity

Wednesday's collapse in VPG stood in stark contrast to the broader market, where the Dow Jones Industrial Average and S&P 500 both climbed to fresh record highs, lifted by strong corporate earnings and optimism surrounding a potential deal to reopen the Strait of Hormuz. The S&P 500 advanced roughly 0.4% to 0.6% while the Nasdaq Composite was little changed, underscoring that VPG's rout was entirely idiosyncratic and not the result of any macroeconomic or sector-wide pressure.

Trading volume in VPG was poised to far exceed its daily average, reflecting intense repositioning by institutional and retail investors alike. The stock had been flagged in recent weeks by multiple analysts as trading at extreme valuation multiples compared to peers, making it particularly vulnerable to any earnings disappointment. The shares, which had touched a 52-week high of $151.78 as recently as late June, crashed through several technical support levels in the session, including its 50-day moving average.

What Comes Next for VPG

Looking ahead, VPG guided for third-quarter revenue in the range of $84 million to $89 million at constant second-quarter exchange rates, a midpoint slightly below the $88.2 million consensus estimate. Management expressed confidence that full-year fiscal 2026 organic revenue growth would exceed the 8% to 10% target outlined in its three-year strategic plan, citing the strength of its backlog, AI-driven demand for precision resistors, and the anticipated ramp in humanoid robotics production.

The burden now falls on the company to demonstrate that its strong order momentum can translate into tangible earnings improvement. Key risks include persistent currency headwinds, execution risk around the KELK ERP recovery, and the possibility that AI-related order strength moderates. With the stock now trading sharply below its recent highs, the next several quarters will be critical in determining whether Wednesday's selloff was an overreaction or a justified repricing of a stock that had gotten ahead of its fundamentals.

Trending AI Robots

For investors seeking a data-driven approach to navigating volatility like the move seen in VPG today, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Hundreds of AI trading bots cover thousands of tickers, but only those demonstrating the strongest real-time performance metrics under prevailing market dynamics are featured in this dedicated section. Bots vary by strategy, timeframe, performance benchmarks, and traded symbols, allowing users to explore automated trading approaches aligned with their objectives. Visit the Trending AI Robots page to explore the top-performing bots and discover how AI-driven strategies can enhance your market analysis toolkit.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VPG

VPG in downward trend: price dove below 50-day moving average on July 13, 2026

VPG moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend. In of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VPG as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for VPG crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VPG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VPG entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VPG's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where VPG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VPG advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

VPG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VPG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.013) is normal, around the industry mean (4.670). P/E Ratio (224.444) is within average values for comparable stocks, (89.768). VPG's Projected Growth (PEG Ratio) (5.611) is slightly higher than the industry average of (2.371). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.207) is also within normal values, averaging (31.210).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 9.61B. The market cap for tickers in the group ranges from 27.54K to 122.53B. KYCCF holds the highest valuation in this group at 122.53B. The lowest valued company is CSEC at 27.54K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 20%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 6%. FCUV experienced the highest price growth at 402%, while MVIS experienced the biggest fall at -93%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 54
Price Growth Rating: 52
SMR Rating: 79
Profit Risk Rating: 78
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
VPG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of foil technology products

Industry ElectronicEquipmentInstruments

Profile
Details
Industry
Electronic Components
Address
3 Great Valley Parkway
Phone
+1 484 321-5300
Employees
2300
Web
https://www.vpgsensors.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.